Phar­ma com­pa­nies in the meta­verse? Maybe not yet, but time to start think­ing fu­ture use, ex­perts say

Thanks to Face­book’s name change to Meta last year, every­one is talk­ing about the meta­verse — es­pe­cial­ly com­pa­nies and brands scram­bling to fig­ure out how they’re go­ing to play on the plat­form. But should phar­ma com­pa­nies be jump­ing in to the meta­verse, what­ev­er it is?

Yes and no, in­dus­try ex­perts say. There are some ini­tial plays for phar­ma, like us­ing aug­ment­ed or vir­tu­al re­al­i­ty to bet­ter show how a drug works or what Parkin­son’s dis­ease tremors feel like. The fu­ture of the meta­verse is still very much in the fu­ture, along with its ma­jor us­es across bio­phar­ma in R&D, pa­tient com­mu­ni­ca­tions, drug launch­es, man­u­fac­tur­ing and mar­ket­ing. But it is on the way.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER